Pulmonary Function Testing Device Market Share, Trend & Forecast

Pulmonary Function Testing Device Market Outlook from 2024 to 2034

The global pulmonary function testing device market is likely to reach US$ 167.3 million by 2024. From 2024 to 2034, the market is slated to expand at a moderate CAGR of 4.8% to reach US$ 268.0 million.

Attributes	Key Insights
Estimated Market Size in 2024	US$ 167.3 million
Projected Market Value in 2034	US$ 268.0 million
Value-based CAGR from 2024 to 2034	4.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Market Trends and Highlights

Chronic respiratory diseases have been rising, surging the demand for respiratory assistance and other medical testing devices.
Governments have been taking assertive steps to spread awareness about these diseases and methods to arrest their spread.
Technological development has allowed manufacturers to produce cutting-edge tools for pulmonary testing.
Key market players have shown interest in developing testing kits by integrating modern technology with devices to improve accuracy.

Demand Analysis of Pulmonary Function Testing Device Market from 2019 to 2023 vs. Outlook from 2024 to 2034

The global pulmonary function testing device market rose between 2019 and 2023 at a CAGR of 6.5% to reach US$ 158.1 million. This growth is attributed to the outbreak of the COVID-19 pandemic. Rising respiratory disorders surged the demand for pulmonary testing kits. This exponential rise in demand propelled the subject market growth.

The declined spike in the number of COVID-19 patients decreases the demand for pulmonary function testing devices compared to the historic period. Due to this reduced demand, a fall in the CAGR can be observed.

However, the demand for respiratory assisting devices will increase due to the increasing geriatric population in many countries, such as the United States and the United Kingdom. This shall propel the market in the forecasted period.

Due to government investments, healthcare infrastructure is developing, giving equal importance to respiratory testing devices, propelling the market in the forecasted period. Advancements in technology and integration into traditional testing units will upsurge pulmonary function testing device requirements.

Historical CAGR from 2019 to 2023	6.5%
Forecast CAGR from 2024 to 2034	4.8%

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Pulmonary Function Testing Device Market Drivers

The prevalence of chronic respiratory diseases induces a market-driving force, which surges the production of pulmonary function devices. This drives the market.
The pulmonary function test devices are easy to use, increasing their popularity among different population classes. Thus, this proves to be an important market driver.
Key players have integrated technology in testing devices, like AI, significantly enhancing test results' accuracy. This surges the demand for test devices to monitor an individual’s health.
Numerous diagnostics advantages favor the use of these devices. Hence, this creates demand in the market, thereby driving the subject market.
Governments have invested in R&D processes that fuel the upliftment of testing devices. Also, the test results delivered are more precise. Hence, this surges the market under consideration.

Pulmonary Function Testing Device Market Challenges

Regulatory frameworks for implementing medical tests are stringent in various regions worldwide. This makes exchanging devices and relevant technology difficult, which restrains the subject market.
From the context of affordability, pulmonary function testing devices have higher costs. This might not be affordable for all people. Due to this, the reach of the market is limited.
Due to fierce competition, the scope for new entrants is limited. Expanding the market in developing countries might be difficult, hindering market growth.

Country-wise Analysis

As far as the forecasted market size is concerned, the United States of America outperforms all the other countries to reach US$ 48.4 million by the end of the forecasted period.

The enhancement in the medical infrastructure creates many opportunities for the global pulmonary testing device market. The innovation of products and integration of modern technology, like AI, become easier, thereby driving the market in North America.

Awareness of lung-related diseases has allowed patients worldwide to become more aware of their health, which has helped the market. Rising lung diseases and government inclining toward investment in the medical sector have helped the market to grow.

Countries	Forecast CAGRs from 2024 to 2034
The United States	5.1%
The United Kingdom	6.0%
Japan	6.4%
South Korea	7.0%
China	5.6%

Pulmonary Function Testing Device Market in the United States

The forecasted CAGR during the next decade is 5.1%.
The total number of lung cancer cases has been rising in the United States. About 236,000 people were suffering from the disease in 2021.
More than 26 million people have had Asthma and need medical support.
These rising cases shall surge the subject market in the forecasted period, as the number of patients requiring monitoring and control tools will increase.
The presence of strong medical infrastructure has been one of the major contributors to the subject market growth in the region.
New entrants and large-scale organizations have driven the demand for new test kits and devices, surging the market.

Pulmonary Function Testing Device Market in the United Kingdom

The United Kingdom's market size is estimated to reach US $10.8 million by 2034, with a moderate CAGR of 6.0%.
The market growth is subjected to increased demand for spirometers. The market segment is forecasted to dominate the English market.
The total number of chronic obstructive pulmonary diseases is rising in the United Kingdom, which is reflected in the increasing demand for pulmonary devices.
The launch of new devices from large-scale organizations creates lucrative opportunities for the market to expand in the country.
The government's investments have boosted the infrastructure needed to increase the production of devices.

Pulmonary Function Testing Device Market in Japan

Japan is forecasted to be Asia’s second-largest market shareholder by 2034, both in terms of the growth rate and the market valuation.
With a CAGR of 5.6%, Japan’s market shall reach US $29.8 million after the forecasted period.
Introducing new products in different market segments has been a crucial market driver for the Japanese market.
Increasing health awareness has promoted the introduction of personalized healthcare devices, including portable pulmonary test devices.
Diversification of large-scale players helps the market grow substantially.

Pulmonary Function Testing Device Market in South Korea

South Korea is forecasted to reach US $17.4 million by 2034 at a moderate CAGR of 7.0%, the largest growth rate for any Asian country for the forecasted period.
The medical infrastructure in the country has been developed, which was accelerated amidst the pandemic outbreak.
International trade accelerates the import of medical devices, fueling the local market’s growth.
The hospital market segment blocks the largest market share for respiratory devices, propelling the subject market growth.
Diagnostics and monitoring devices have been performing excessively well, helping the South Korean market grow.

Pulmonary Function Testing Device Market in China

The Chinese pulmonary function device testing market is forecasted to be the second-largest market by market value, reaching US$ 42.3 million by 2034. However, this market advancement is at a moderate CAGR of 5.6%.
The origin and growth of the COVID-19 virus increased the prevalence of respiratory disorders, which is expected to grow, propelling the market's growth.
Large-scale organizations have been collaborating to produce better treatments for pulmonary disorders, which fuels the demand for relevant devices.
Technological advancements leverage the efficient production of testing devices.
The surge in pulse oximeters is forecasted to grow, which accompanies the growth of the subject market.

Category-wise Insights

This section emphasizes the contribution of different market segments and the marketplace secured by these segments.

Based on product type, handheld devices contribute substantially to the market by blocking 60% of the market. Further, spirometry is the test-type market segment, securing about 46% of the market share among other market segments.

Category	CAGR from 2024 to 2034
Handheld Devices	4.6%
Spirometry Test	4.4%

Handheld Devices to Lead the Product Type Market Segment

Handheld pulmonary devices form an important market segment for the global pulmonary function testing device market.

The fundamental reason for this is the portability of devices. These portable devices can control the patient’s health remotely. This remote handling has been leveraging operators’ comfort.

Consequently, this was the largest market shareholding segment, accounting for about 60% of the market. Additionally, the commercialization of these products will lead to sluggish advancement of the said market segment at a CAGR of 4.4% during the forecasted period, which will boost the subject market.

Spirometry Test Will Gain Popularity in the Forecasted Period

Various key players have been investing more in technological infrastructure. Marketers have focused on R&D to improve instruments for performing different tests and diagnostic techniques. The accuracy of the results gained has also increased drastically, leading to the evolution of spirometers.

Further, integrating artificial intelligence with traditional spirometers has made the new devices more accurate and precise.

Consequently, this results in a substantial market share for the spirometry market segment, which accounts for about 46% of the entire market. The market segment is estimated to advance at a CAGR of 4.4%.

Competitive Landscape

The presence of large-scale organizations clutters the global pulmonary function testing device market. Various organizations have adopted different expansion methods that promote their growth within the market.

Organizations' strategic initiatives to expand in the market include developing new products, research collaborations, forward integration, mergers, partnerships, geographical expansions, and many more.

The reliance of organizations on cutting-edge technology is fueling innovation within the sector. Technological integration has allowed marketers to pivot their products for optimum patient comfort. Some of the important market players include

Koninklijke Philips N.V.
Medical Equipment Europe
Medtronic
Minato Holdings Inc.
Morgan Scientific Inc.

Key Market Developments

In May 2023, Medtronic acquired EOFlow Co. Ltd. which manufactures wearable, tubeless, and disposable insulin delivery devices. This strategic initiative will allow the organization to penetrate the market.
In February 2024, Philips introduced a high-power and fast-motorized mobile C-arm. This medical arm is estimated to assist surgeons in delivering optimum patient comfort and better precision in surgical operations.

Key Coverage of the Pulmonary Function Testing Device Market Report

Adjacent studies on Pulmonary Function Testing Device Market
Chronic Obstructive Pulmonary Disease Testing Market
Current market scenario for the Pulmonary Function Testing Device Market
Pulmonary Function Testing Machine Price
Pulmonary Function Testing Device Market Share
Pulmonary Function Testing Device Market Players

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 167.3 million
Projected Market Valuation in 2034	US$ 268.0 million
Value-based CAGR 2024 to 2034	4.8%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ million
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	Product Type Test Type Application End-Use Region
Key Countries Profiled	The United States United Kingdom China Japan South Korea
Key Companies Profiled	Koninklijke Philips N.V. Medical Equipment Europe Medtronic Minato Holdings Inc. Morgan Scientific Inc.

Pulmonary Function Testing Device Market- Key Segments

By Product Type:

Handheld
Tabletop

By Test Type:

Spirometry
Lung Volume Test
Gas Diffusion Test
Exercise Stress Test
High Altitude Simulation Testing
Others

By Application:

Chronic Obstructive Pulmonary Disease
Asthma
Pulmonary Fibrosis
Others

By End Use:

Hospitals & Clinics
Diagnostic Centers
Homecare Settings
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

Frequently Asked Questions

What is the expected value of the pulmonary function testing device market in 2034?

The global pulmonary function testing device market shall reach US$ 268.0 million by 2034.

What is the anticipated CAGR for the pulmonary function testing device ecosystem from 2024 to 2034?

The global pulmonary function testing device market will advance at a moderate CAGR of 4.8%.

Based on the type of device, which market segment is anticipated to lead?

Based on device type, handheld devices will lead the market with 60% of the market share based on the device type of test.

By test type, which category leads in the pulmonary function testing device market?

Based on test type, spirometry will lead the market with a 46% share.

What is the estimated market value of the global pulmonary function testing device market in 2024?

The global pulmonary function testing device market is expected to reach US$ 167.3 million by 2024.

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034
        5.3.1. Handheld
        5.3.2. Tabletop
    5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
    5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2019 to 2023
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2024 to 2034
        6.3.1. Spirometry
        6.3.2. Lung Volume Test
        6.3.3. Gas Diffusion Test
        6.3.4. Exercise Stress Test
        6.3.5. High Altitude Simulation Testing
        6.3.6. Others
    6.4. Y-o-Y Growth Trend Analysis By Test Type, 2019 to 2023
    6.5. Absolute $ Opportunity Analysis By Test Type, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
        7.3.1. Chronic Obstructive Pulmonary Disease
        7.3.2. Asthma
        7.3.3. Chronic Shortness of Breath
        7.3.4. Pulmonary Fibrosis
        7.3.5. Others
    7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
    7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2019 to 2023
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2024 to 2034
        8.3.1. Hospitals & Clinics
        8.3.2. Diagnostic Centres
        8.3.3. Homecare Settings
        8.3.4. Others
    8.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023
    8.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. South Asia and Pacific
        9.3.6. East Asia
        9.3.7. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        10.2.1. By Country
            10.2.1.1. USA
            10.2.1.2. Canada
        10.2.2. By Product
        10.2.3. By Test Type
        10.2.4. By Application
        10.2.5. By End-User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By Test Type
        10.3.4. By Application
        10.3.5. By End-User
    10.4. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Product
        11.2.3. By Test Type
        11.2.4. By Application
        11.2.5. By End-User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Test Type
        11.3.4. By Application
        11.3.5. By End-User
    11.4. Key Takeaways
12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. UK
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Rest of Western Europe
        12.2.2. By Product
        12.2.3. By Test Type
        12.2.4. By Application
        12.2.5. By End-User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Test Type
        12.3.4. By Application
        12.3.5. By End-User
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        13.2.1. By Country
            13.2.1.1. Poland
            13.2.1.2. Russia
            13.2.1.3. Czech Republic
            13.2.1.4. Romania
            13.2.1.5. Rest of Eastern Europe
        13.2.2. By Product
        13.2.3. By Test Type
        13.2.4. By Application
        13.2.5. By End-User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Test Type
        13.3.4. By Application
        13.3.5. By End-User
    13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        14.2.1. By Country
            14.2.1.1. India
            14.2.1.2. Bangladesh
            14.2.1.3. Australia
            14.2.1.4. New Zealand
            14.2.1.5. Rest of South Asia and Pacific
        14.2.2. By Product
        14.2.3. By Test Type
        14.2.4. By Application
        14.2.5. By End-User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Test Type
        14.3.4. By Application
        14.3.5. By End-User
    14.4. Key Takeaways
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        15.2.1. By Country
            15.2.1.1. China
            15.2.1.2. Japan
            15.2.1.3. South Korea
        15.2.2. By Product
        15.2.3. By Test Type
        15.2.4. By Application
        15.2.5. By End-User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Test Type
        15.3.4. By Application
        15.3.5. By End-User
    15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Israel
            16.2.1.4. Rest of MEA
        16.2.2. By Product
        16.2.3. By Test Type
        16.2.4. By Application
        16.2.5. By End-User
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Product
        16.3.3. By Test Type
        16.3.4. By Application
        16.3.5. By End-User
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. USA
        17.1.1. Market Share Analysis, 2023
            17.1.1.1. By Product
            17.1.1.2. By Test Type
            17.1.1.3. By Application
            17.1.1.4. By End-User
    17.2. Canada
        17.2.1. Market Share Analysis, 2023
            17.2.1.1. By Product
            17.2.1.2. By Test Type
            17.2.1.3. By Application
            17.2.1.4. By End-User
    17.3. Brazil
        17.3.1. Market Share Analysis, 2023
            17.3.1.1. By Product
            17.3.1.2. By Test Type
            17.3.1.3. By Application
            17.3.1.4. By End-User
    17.4. Mexico
        17.4.1. Market Share Analysis, 2023
            17.4.1.1. By Product
            17.4.1.2. By Test Type
            17.4.1.3. By Application
            17.4.1.4. By End-User
    17.5. Germany
        17.5.1. Market Share Analysis, 2023
            17.5.1.1. By Product
            17.5.1.2. By Test Type
            17.5.1.3. By Application
            17.5.1.4. By End-User
    17.6. UK
        17.6.1. Market Share Analysis, 2023
            17.6.1.1. By Product
            17.6.1.2. By Test Type
            17.6.1.3. By Application
            17.6.1.4. By End-User
    17.7. France
        17.7.1. Market Share Analysis, 2023
            17.7.1.1. By Product
            17.7.1.2. By Test Type
            17.7.1.3. By Application
            17.7.1.4. By End-User
    17.8. Spain
        17.8.1. Market Share Analysis, 2023
            17.8.1.1. By Product
            17.8.1.2. By Test Type
            17.8.1.3. By Application
            17.8.1.4. By End-User
    17.9. Italy
        17.9.1. Market Share Analysis, 2023
            17.9.1.1. By Product
            17.9.1.2. By Test Type
            17.9.1.3. By Application
            17.9.1.4. By End-User
    17.10. Poland
        17.10.1. Market Share Analysis, 2023
            17.10.1.1. By Product
            17.10.1.2. By Test Type
            17.10.1.3. By Application
            17.10.1.4. By End-User
    17.11. Russia
        17.11.1. Market Share Analysis, 2023
            17.11.1.1. By Product
            17.11.1.2. By Test Type
            17.11.1.3. By Application
            17.11.1.4. By End-User
    17.12. Czech Republic
        17.12.1. Market Share Analysis, 2023
            17.12.1.1. By Product
            17.12.1.2. By Test Type
            17.12.1.3. By Application
            17.12.1.4. By End-User
    17.13. Romania
        17.13.1. Market Share Analysis, 2023
            17.13.1.1. By Product
            17.13.1.2. By Test Type
            17.13.1.3. By Application
            17.13.1.4. By End-User
    17.14. India
        17.14.1. Market Share Analysis, 2023
            17.14.1.1. By Product
            17.14.1.2. By Test Type
            17.14.1.3. By Application
            17.14.1.4. By End-User
    17.15. Bangladesh
        17.15.1. Market Share Analysis, 2023
            17.15.1.1. By Product
            17.15.1.2. By Test Type
            17.15.1.3. By Application
            17.15.1.4. By End-User
    17.16. Australia
        17.16.1. Market Share Analysis, 2023
            17.16.1.1. By Product
            17.16.1.2. By Test Type
            17.16.1.3. By Application
            17.16.1.4. By End-User
    17.17. New Zealand
        17.17.1. Market Share Analysis, 2023
            17.17.1.1. By Product
            17.17.1.2. By Test Type
            17.17.1.3. By Application
            17.17.1.4. By End-User
    17.18. China
        17.18.1. Market Share Analysis, 2023
            17.18.1.1. By Product
            17.18.1.2. By Test Type
            17.18.1.3. By Application
            17.18.1.4. By End-User
    17.19. Japan
        17.19.1. Market Share Analysis, 2023
            17.19.1.1. By Product
            17.19.1.2. By Test Type
            17.19.1.3. By Application
            17.19.1.4. By End-User
    17.20. South Korea
        17.20.1. Market Share Analysis, 2023
            17.20.1.1. By Product
            17.20.1.2. By Test Type
            17.20.1.3. By Application
            17.20.1.4. By End-User
    17.21. GCC Countries
        17.21.1. Market Share Analysis, 2023
            17.21.1.1. By Product
            17.21.1.2. By Test Type
            17.21.1.3. By Application
            17.21.1.4. By End-User
    17.22. South Africa
        17.22.1. Market Share Analysis, 2023
            17.22.1.1. By Product
            17.22.1.2. By Test Type
            17.22.1.3. By Application
            17.22.1.4. By End-User
    17.23. Israel
        17.23.1. Market Share Analysis, 2023
            17.23.1.1. By Product
            17.23.1.2. By Test Type
            17.23.1.3. By Application
            17.23.1.4. By End-User
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Product
        18.3.3. By Test Type
        18.3.4. By Application
        18.3.5. By End-User
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Koninklijke Philips N.V
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
        19.1.2. Minato Holdings Inc
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
        19.1.3. Medtronic
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
        19.1.4. Morgan Scientific Inc
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
        19.1.5. SCHILLER
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
        19.1.6. ndd Medizintechnik AG
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
        19.1.7. Medical Equipment Europe
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
        19.1.8. Ganshorn Medizin Electronic
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
        19.1.9. CHEST M.I., Inc
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
        19.1.10. Vyaire Medical, Inc
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology

Pulmonary Function Testing Device Market

Pulmonary Function Testing Device Market Analysis by Handheld and Tabletop Product Types and Tests such as Spirometry from 2024 to 2034